Potential impact of Helicobacter pylori infection on primary-angle closure glaucoma and primary open-angle glaucoma pathophysiology
Neuroscience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Helicobacter pylori infection in the pathophysiology of metabolic dysfunction-associated steatotic liver disease and its complications
Published: March 20, 2025
Language: Английский
Letter: Role of Helicobacter pylori and metabolic syndrome‐related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH
Alimentary Pharmacology & Therapeutics,
Journal Year:
2024,
Volume and Issue:
60(5), P. 660 - 661
Published: July 30, 2024
LINKED
CONTENT
This
article
is
linked
to
Lin
et
al
papers.
To
view
these
articles,
visit
https://doi.org/10.1111/apt.17930
and
https://doi.org/10.1111/apt.18182
.
Language: Английский
Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease
Alimentary Pharmacology & Therapeutics,
Journal Year:
2024,
Volume and Issue:
60(4), P. 540 - 541
Published: July 3, 2024
LINKED
CONTENT
This
article
is
linked
to
Dominik
et
al
papers.
To
view
these
articles,
visit
https://doi.org/10.1111/apt.17945
and
https://doi.org/10.1111/apt.18144
Language: Английский
The 1st EoETALY consensus on the diagnosis and management of eosinophilic esophagitis and the missing link: Helicobacter pylori infection
Digestive and Liver Disease,
Journal Year:
2024,
Volume and Issue:
56(11), P. 1946 - 1947
Published: July 26, 2024
Language: Английский
Helicobacter pylori Infection and Cholelithiasis
Journal of Gastroenterology and Hepatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 18, 2024
Language: Английский
Causal associations of Helicobacter pylori infection and metabolic syndrome: insights from a two-sample Mendelian randomization study
Hongwei Wang,
No information about this author
Fangying Tian,
No information about this author
C W. Yang
No information about this author
et al.
Diabetology & Metabolic Syndrome,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Nov. 26, 2024
Helicobacter
pylori
(Hp)
infection
and
metabolic
syndrome
(MetS)
have
a
high
prevalence
of
co-morbidities
both
pose
significant
threat
to
human
health
survival.
It
has
been
suggested
that
Hp
affects
the
development
MetS
in
host,
but
causal
relationship
between
two
not
confirmed.
We
conducted
two-sample
Mendelian
randomization
study
investigate
effect
with
its
components.
Summary
statistics
for
exposure
factors
(Hp
infection)
were
obtained
from
GWAS
Catalog
(anti-Hp
IgG,
n
=
8,735;
VacA
antibody
levels,
1,571;
GroEL
2,716;
OMP
2,640).
outcome
most
comprehensive
genome-wide
association
(GWAS)
currently
available
(n
291,107)
as
well
components
MetS:
fasting
glucose
46,186),
hypertension
461,880),
serum
triglycerides
115,082),
waist
circumference
21,949),
high-density
lipoprotein
400,
754).
The
inverse-variance
weighted
(IVW)
method
was
used
primary
MR
robustness
results
assessed
through
sensitivity
analyses.
analysis
showed
anti-Hp
IgG
levels
positively
correlated
(β
0.08,
P
0.012),
an
opposite
correlation
HDL
(β=
-0.03,
0.025)
TG
0.02,
0.045).
In
contrast,
antibodies
FBG
0.064,
0.037
β
0.09,
0.003).
estimation
IVW
main
method,
level
associated
negatively
0.008
β=
-0.02,
0.007).
Meanwhile,
analyses
no
heterogeneity
or
pleiotropy.
Our
suggests
there
is
Mets
diagnosis
composition,
further
studies
are
needed
understand
mechanism
influence.
Language: Английский